JP Morgan Chase’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Buy
42,500
+27,500
+183% +$2.83M ﹤0.01% 3619
2025
Q4
$1.43M Hold
15,000
﹤0.01% 4361
2025
Q3
$1.48M Hold
15,000
﹤0.01% 4304
2025
Q2
$1.6M Hold
15,000
﹤0.01% 4082
2025
Q1
$1.37M Hold
15,000
﹤0.01% 4134
2024
Q4
$1.71M Hold
15,000
﹤0.01% 4266
2024
Q3
$1.78M Buy
15,000
+3,400
+29% +$313K ﹤0.01% 4088
2024
Q2
$932K Buy
+11,600
New +$1.06M ﹤0.01% 4323
2023
Q1
Sell
-4,000
Closed -$601K 6703
2022
Q4
$601K Buy
+4,000
New +$616K ﹤0.01% 4397
2022
Q1
Sell
-14,400
Closed -$3.71M 6603
2021
Q4
$3.71M Buy
14,400
+8,000
+125% +$2.19M ﹤0.01% 3308
2021
Q3
$1.75M Sell
6,400
-11,000
-63% -$3.5M ﹤0.01% 3890
2021
Q2
$3.9M Sell
17,400
-32,500
-65% -$6.13M ﹤0.01% 3272
2021
Q1
$5.45M Sell
49,900
-28,300
-36% -$3.01M ﹤0.01% 2890
2020
Q4
$6.38M Sell
78,200
-194,300
-71% -$19.1M ﹤0.01% 2601
2020
Q3
$18.2M Buy
+272,500
New +$19.6M ﹤0.01% 1553

Other funds holding BNTX

JP Morgan Chase's BNTX Position: Q1 2026 in Review

JP Morgan Chase increased its BioNTech (BNTX) stake by 4.1% in Q1 2026, buying an estimated $470K and bringing the position to 117,268 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

JP Morgan Chase first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $10.7M in Q4 2025. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • JP Morgan Chase held 117,268 shares of BioNTech worth $10M as of Q1 2026.
  • JP Morgan Chase bought 4,571 BioNTech shares in Q1 2026, an estimated $470K.
  • BioNTech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2670 holding.
  • JP Morgan Chase first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
  • JP Morgan Chase's BioNTech position peaked at $10.7M in Q4 2025.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.